It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 03850cam 2200757 a 4500
001 ocm52513079
003 OCoLC
005 20200514035336.0
008 040316s2003 nyua b 001 0 eng
010 $a 2004270533
040 $aNLM$beng$cNLM$dDLC$dUAT$dCUX$dMUQ$dUGX$dBAKER$dVRC$dBTCTA$dCGC$dYDXCP$dBDX$dOCLCF$dNJI$dOCLCQ$dOCLCO$dOCLCA$dCASUM
016 7 $a101189343$2DNLM
019 $a55231183$a1049812201
020 $a0824740416$q(alk. paper)
020 $a9780824740412$q(alk. paper)
035 $a(OCoLC)52513079$z(OCoLC)55231183$z(OCoLC)1049812201
042 $anlmcopyc
050 00 $aRM267$b.M613 2003
060 00 $a2003 K-537
060 10 $aQV38$bM6253 2003
082 00 $a615/.329$222
245 00 $aMicrobial genomics and drug discovery /$cedited by Thomas J. Dougherty, Steven J. Projan.
260 $aNew York :$bMarcel Dekker,$c℗♭2003.
300 $axi, 243 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $a1. Global aspects of antibiotic resistance -- 2. Genomics of bacterial pathogens -- 3. Bioinformatics, genomics, and antimicrobial drug discovery -- 4. The pathway tools software and its role in antimicrobial drug discovery -- 5. Genomic strategies in antibacterial drug discovery -- 6. Genomics-based approaches to novel antimicrobial target discovery -- 7. Pathogenesis genes as novel targets -- 8. Application of genomics to the discovery of new drugs against tuberculosis -- 9. Phenotype microarrays: Their use in antibiotic discovery -- 10. Microbial proteomics: New approaches for therapeutic vaccines and drug discovery -- 11. Surrogate ligand-based assay systems for discovery of antibacterial agents for genomic targets -- 12. Expression profiling uses in antibacterial chemotherapy development -- 13. Using fungal genomes for the discovery, development, and clinical application of novel and current antifungal therapeutics -- 14. Genomics in novel natural products generation.
650 0 $aAntibiotics.
650 0 $aMicrobial genetics.
650 0 $aGene mapping.
650 0 $aGenomics.
650 0 $aPharmacogenomics.
650 0 $aDrug development.
650 12 $aPharmacogenetics.
650 12 $aGenetics, Microbial.
650 22 $aDrug Resistance, Microbial$xgenetics.
650 22 $aDrug Evaluation$xmethods.
650 6 $aAntibiotiques.
650 6 $aGe ne tique microbienne.
650 6 $aCartes chromosomiques.
650 6 $aGe nomique.
650 6 $aPharmacoge nomique.
650 6 $aMe dicaments$xDe veloppement.
650 7 $aAntibiotics.$2fast$0(OCoLC)fst00810420
650 7 $aDrug development.$2fast$0(OCoLC)fst00898670
650 7 $aGene mapping.$2fast$0(OCoLC)fst00939625
650 7 $aGenomics.$2fast$0(OCoLC)fst00940228
650 7 $aMicrobial genetics.$2fast$0(OCoLC)fst01019500
650 7 $aPharmacogenomics.$2fast$0(OCoLC)fst01060245
655 4 $aFulltext.
655 4 $aInternet Resources.
700 1 $aDougherty, Thomas J.$q(Thomas John),$d1950-
700 1 $aProjan, Steve.
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/fy044/2004270533.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/enhancements/fy0647/2004270533-d.html
856 41 $uhttp://www.crcnetbase.com/isbn/9780824740412$zAccess restricted to Stanford community$yFulltext
938 $aBaker & Taylor$bBKTY$c189.95$d189.95$i0824740416$n0004236361$sactive
938 $aBrodart$bBROD$n00757756$c$179.95
938 $aBaker and Taylor$bBTCP$n2004270533
938 $aYBP Library Services$bYANK$n1983237
029 1 $aAU@$b000024826691
029 1 $aNLM$b101189343
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 109 OTHER HOLDINGS